{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:42:50Z","timestamp":1790520170295,"version":"4.1.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13054-019-2460-3","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T14:03:47Z","timestamp":1557842627000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Is systematic fecal carriage screening of extended-spectrum beta-lactamase-producing Enterobacteriaceae still useful in intensive care unit: a systematic review"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2942-7350","authenticated-orcid":false,"given":"Renaud","family":"Prevel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"M\u2019Zali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Lasheras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Ralph","family":"Zahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Rogues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Gruson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,14]]},"reference":[{"key":"2460_CR1","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1093\/cid\/civ196","volume":"60","author":"J Carlet","year":"2015","unstructured":"Carlet J. The world alliance against antibiotic resistance: consensus for a declaration. Clin Infect Dis. 2015;60:1837\u201341.","journal-title":"Clin Infect Dis"},{"key":"2460_CR2","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1128\/CMR.00023-13","volume":"26","author":"P-L Woerther","year":"2013","unstructured":"Woerther P-L, Burdet C, Chachaty E, Andremont A. Trends in human fecal carriage of extended-spectrum -lactamases in the community: toward the globalization of CTX-M. Clin Microbiol Rev. 2013;26:744\u201358.","journal-title":"Clin Microbiol Rev"},{"key":"2460_CR3","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.ijantimicag.2017.08.003","volume":"50","author":"ME Flokas","year":"2017","unstructured":"Flokas ME, Alevizakos M, Shehadeh F, Andreatos N, Mylonakis E. Extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae colonisation in long-term care facilities: a systematic review and meta-analysis. Int J Antimicrob Agents. 2017;50:649\u201356.","journal-title":"Int J Antimicrob Agents"},{"key":"2460_CR4","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1093\/jac\/dks429","volume":"68","author":"M-H Nicolas-Chanoine","year":"2013","unstructured":"Nicolas-Chanoine M-H, Gruson C, Bialek-Davenet S, Bertrand X, Thomas-Jean F, Bert F, et al. 10-fold increase (2006-11) in the rate of healthy subjects with extended-spectrum -lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre. J Antimicrob Chemother. 2013;68:562\u20138.","journal-title":"J Antimicrob Chemother"},{"key":"2460_CR5","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1586\/eri.13.4","volume":"11","author":"GS Tansarli","year":"2013","unstructured":"Tansarli GS, Karageorgopoulos DE, Kapaskelis A, Falagas ME. Impact of antimicrobial multidrug resistance on inpatient care cost: an evaluation of the evidence. Expert Rev Anti-Infect Ther. 2013;11:321\u201331.","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"2460_CR6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jhin.2015.10.001","volume":"92","author":"JA Maslikowska","year":"2016","unstructured":"Maslikowska JA, Walker SAN, Elligsen M, Mittmann N, Palmay L, Daneman N, et al. Impact of infection with extended-spectrum \u03b2-lactamase-producing Escherichia coli or Klebsiella species on outcome and hospitalization costs. J Hosp Infect. 2016;92:33\u201341.","journal-title":"J Hosp Infect"},{"key":"2460_CR7","first-page":"667","volume":"71","author":"E Esteve-Palau","year":"2015","unstructured":"Esteve-Palau E, Solande G, S\u00e1nchez F, Sorl\u00ed L, Montero M, G\u00fcerri R, et al. Clinical and economic impact of urinary tract infections caused by ESBL-producing Escherichia coli requiring hospitalization: a matched cohort study. J Inf Secur. 2015;71:667\u201374.","journal-title":"J Inf Secur"},{"key":"2460_CR8","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s15010-014-0670-9","volume":"42","author":"R Leistner","year":"2014","unstructured":"Leistner R, G\u00fcrntke S, Sakellariou C, Denkel LA, Bloch A, Gastmeier P, et al. Bloodstream infection due to extended-spectrum beta-lactamase (ESBL)-positive K. pneumoniae and E. coli: an analysis of the disease burden in a large cohort. Infection. 2014;42:991\u20137.","journal-title":"Infection"},{"key":"2460_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/1469-0691.12427","volume":"20","author":"E Tacconelli","year":"2014","unstructured":"Tacconelli E, Cataldo MA, Dancer SJ, De Angelis G, Falcone M, Frank U, et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect. 2014;20:1\u201355.","journal-title":"Clin Microbiol Infect"},{"key":"2460_CR10","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1111\/j.1469-0691.2009.03024.x","volume":"16","author":"A March","year":"2010","unstructured":"March A, Aschbacher R, Dhanji H, Livermore DM, B\u00f6ttcher A, Sleghel F, et al. Colonization of residents and staff of a long-term-care facility and adjacent acute-care hospital geriatric unit by multiresistant bacteria. Clin Microbiol Infect. 2010;16:934\u201344.","journal-title":"Clin Microbiol Infect"},{"key":"2460_CR11","doi-asserted-by":"crossref","unstructured":"Price LB, Johnson JR, Aziz M, Clabots C, Johnston B, Tchesnokova V, et al. The epidemic of extended-spectrum-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx. mBio. 2013;4 Available from: \n                    http:\/\/mbio.asm.org\/cgi\/doi\/10.1128\/mBio.00377-13\n                    \n                  . [cited 2018 Oct 31].","DOI":"10.1128\/mBio.00377-13"},{"key":"2460_CR12","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/BF01647010","volume":"18","author":"A Bauernfeind","year":"1990","unstructured":"Bauernfeind A, Grimm H, Schweighart S. A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. Infection. 1990;18:294\u20138.","journal-title":"Infection"},{"key":"2460_CR13","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1016\/j.ajic.2007.10.007","volume":"35","author":"JD Siegel","year":"2007","unstructured":"Siegel JD, Rhinehart E, Jackson M, Chiarello L. 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control. 2007;35:S65\u2013164.","journal-title":"Am J Infect Control"},{"key":"2460_CR14","doi-asserted-by":"publisher","first-page":"e62678","DOI":"10.1371\/journal.pone.0062678","volume":"8","author":"CF Lowe","year":"2013","unstructured":"Lowe CF, Katz K, McGeer AJ, Muller MP. For the Toronto ESBL working group. Efficacy of admission screening for extended-spectrum beta-lactamase producing Enterobacteriaceae. Kluytmans J, editor. PLoS One. 2013;8:e62678.","journal-title":"PLoS One"},{"key":"2460_CR15","first-page":"81","volume-title":"Pr\u00e9vention de la transmission crois\u00e9e: pr\u00e9cations compl\u00e9mentaires contact","author":"Soci\u00e9t\u00e9 fran\u00e7aise d\u2019hygi\u00e8ne hospitali\u00e8re (SF2H)","year":"2009","unstructured":"Soci\u00e9t\u00e9 fran\u00e7aise d\u2019hygi\u00e8ne hospitali\u00e8re (SF2H). Pr\u00e9vention de la transmission crois\u00e9e: pr\u00e9cations compl\u00e9mentaires contact; 2009;XII. p. 81."},{"key":"2460_CR16","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1093\/cid\/ciw283","volume":"63","author":"S Karanika","year":"2016","unstructured":"Karanika S, Karantanos T, Arvanitis M, Grigoras C, Mylonakis E. Fecal colonization with extended-spectrum beta-lactamase\u2013producing Enterobacteriaceae and risk factors among healthy individuals: a systematic review and metaanalysis. Clin Infect Dis. 2016;63:310\u20138.","journal-title":"Clin Infect Dis"},{"key":"2460_CR17","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1128\/AAC.01823-12","volume":"57","author":"L Armand-Lef\u00e8vre","year":"2013","unstructured":"Armand-Lef\u00e8vre L, Angebault C, Barbier F, Hamelet E, Defrance G, Rupp\u00e9 E, et al. Emergence of imipenem-resistant Gram-negative bacilli in intestinal flora of intensive care patients. Antimicrob Agents Chemother. 2013;57:1488\u201395.","journal-title":"Antimicrob Agents Chemother"},{"key":"2460_CR18","doi-asserted-by":"publisher","first-page":"5131","DOI":"10.1128\/AAC.00607-13","volume":"57","author":"M McLaughlin","year":"2013","unstructured":"McLaughlin M, Advincula MR, Malczynski M, Qi C, Bolon M, Scheetz MH. Correlations of antibiotic use and carbapenem resistance in Enterobacteriaceae. Antimicrob Agents Chemother. 2013;57:5131\u20133.","journal-title":"Antimicrob Agents Chemother"},{"key":"2460_CR19","doi-asserted-by":"crossref","unstructured":"Bruy\u00e8re R, Vigneron C, Bador J, Aho S, Toitot A, Quenot J-P, et al. Significance of prior digestive colonization with extended-spectrum \u03b2-lactamase\u2013producing Enterobacteriaceae in patients with ventilator-associated pneumonia. Crit Care Med. 2016;44(4):699\u2013706.","DOI":"10.1097\/CCM.0000000000001471"},{"key":"2460_CR20","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-015-3853-7","volume":"41","author":"C Bretonni\u00e8re","year":"2015","unstructured":"Bretonni\u00e8re C, Leone M, Mil\u00e9si C, Allaouchiche B, Armand-Lefevre L, Baldesi O, et al. Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric). Intensive Care Med. 2015;41:1181\u201396.","journal-title":"Intensive Care Med"},{"key":"2460_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/2047-2994-1-39","volume":"1","author":"J Carlet","year":"2012","unstructured":"Carlet J. The gut is the epicentre of antibiotic resistance. Antimicrob Resist Infect Control. 2012;1:39.","journal-title":"Antimicrob Resist Infect Control"},{"key":"2460_CR22","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1128\/JCM.34.10.2448-2453.1996","volume":"34","author":"A Gori","year":"1996","unstructured":"Gori A, Espinasse F, Deplano A, Nonhoff C, Nicolas MH, Struelens MJ. Comparison of pulsed-field gel electrophoresis and randomly amplified DNA polymorphism analysis for typing extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae. J Clin Microbiol. 1996;34:2448\u201353.","journal-title":"J Clin Microbiol"},{"key":"2460_CR23","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1086\/502305","volume":"25","author":"M Thouverez","year":"2004","unstructured":"Thouverez M, Talon D, Bertrand X. Control of Enterobacteriaceae producing extended-spectrum beta-lactamase in intensive care units: rectal screening may not be needed in non-epidemic situations. Infect Control Hosp Epidemiol. 2004;25:838\u201341.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2460_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ajic.2006.09.011","volume":"35","author":"AD Harris","year":"2007","unstructured":"Harris AD, Kotetishvili M, Shurland S, Johnson JA, Morris JG, Nemoy LL, et al. How important is patient-to-patient transmission in extended-spectrum \u03b2-lactamase Escherichia coli acquisition. Am J Infect Control. 2007;35:97\u2013101.","journal-title":"Am J Infect Control"},{"key":"2460_CR25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3343\/alm.2014.34.1.20","volume":"34","author":"J Kim","year":"2014","unstructured":"Kim J, Lee JY, Kim SI, Song W, Kim J-S, Jung S, et al. Rates of fecal transmission of extended-spectrum \u03b2-lactamase-producing and carbapenem-resistant Enterobacteriaceae among patients in intensive care units in Korea. Ann Lab Med. 2014;34:20\u20135.","journal-title":"Ann Lab Med"},{"key":"2460_CR26","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jhin.2015.01.018","volume":"90","author":"N O\u2019Connell","year":"2015","unstructured":"O\u2019Connell N, Keating D, Kavanagh J, Schaffer K. Detection and characterization of extended-spectrum beta-lactamase-producing Enterobacteriaceae in high-risk patients in an Irish tertiary care hospital. J Hosp Infect. 2015;90:102\u20137.","journal-title":"J Hosp Infect"},{"key":"2460_CR27","doi-asserted-by":"crossref","unstructured":"Alves M, Lemire A, Decr\u00e9 D, Margetis D, Big\u00e9 N, Pichereau C, et al. Extended-spectrum beta-lactamase \u2212 producing enterobacteriaceae in the intensive care unit: acquisition does not mean cross-transmission. BMC Infect Dis. 2016;16 Available from: \n                    http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-016-1489-z\n                    \n                  . [cited 2018 Oct 31].","DOI":"10.1186\/s12879-016-1489-z"},{"key":"2460_CR28","doi-asserted-by":"crossref","unstructured":"Repess\u00e9 X, Artiguenave M, Paktoris-Papine S, Espinasse F, Dinh A, Charron C, et al. Epidemiology of extended-spectrum beta-lactamase-producing Enterobacteriaceae in an intensive care unit with no single rooms. Ann Intensive Care. 2017;7 Available from: \n                    http:\/\/annalsofintensivecare.springeropen.com\/articles\/10.1186\/s13613-017-0295-0\n                    \n                  . [cited 2018 Oct 31].","DOI":"10.1186\/s13613-017-0295-0"},{"key":"2460_CR29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S1473-3099(13)70295-0","volume":"14","author":"LPG Derde","year":"2014","unstructured":"Derde LPG, Cooper BS, Goossens H, Malhotra-Kumar S, Willems RJL, Gniadkowski M, et al. Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial. Lancet Infect Dis. 2014;14:31\u20139.","journal-title":"Lancet Infect Dis"},{"key":"2460_CR30","doi-asserted-by":"publisher","first-page":"429.e7","DOI":"10.1016\/j.cmi.2017.08.005","volume":"24","author":"W Jalalza\u00ef","year":"2018","unstructured":"Jalalza\u00ef W, Boutrot M, Guinard J, Guigon A, Bret L, Poisson D-M, et al. Cessation of screening for intestinal carriage of extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae in a low-endemicity intensive care unit with universal contact precautions. Clin Microbiol Infect. 2018;24:429.e7\u2013429.e12.","journal-title":"Clin Microbiol Infect"},{"key":"2460_CR31","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1017\/ice.2017.196","volume":"38","author":"L Renaudin","year":"2017","unstructured":"Renaudin L, Llorens M, Goetz C, Gette S, Citro V, Poulain S, et al. Impact of discontinuing contact precautions for MRSA and ESBLE in an intensive care unit: a prospective noninferiority before and after study. Infect Control Hosp Epidemiol. 2017;38:1342\u201350.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2460_CR32","doi-asserted-by":"publisher","first-page":"e017402","DOI":"10.1136\/bmjopen-2017-017402","volume":"7","author":"L Karda\u015b-S\u0142oma","year":"2017","unstructured":"Karda\u015b-S\u0142oma L, Lucet J-C, Perozziello A, Pelat C, Birgand G, Rupp\u00e9 E, et al. Universal or targeted approach to prevent the transmission of extended-spectrum beta-lactamase-producing Enterobacteriaceae in intensive care units: a cost-effectiveness analysis. BMJ Open. 2017;7:e017402.","journal-title":"BMJ Open"},{"key":"2460_CR33","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3166\/rea-2018-0042","volume":"27","author":"A Lepape","year":"2018","unstructured":"Lepape A, Machut A, Savey A. R\u00e9seau national R\u00e9a-Raisin de surveillance des infections acquises en r\u00e9animation adulte - M\u00e9thodes et principaux r\u00e9sultats. M\u00e9d Intensive R\u00e9animation. 2018;27:197\u2013203.","journal-title":"M\u00e9d Intensive R\u00e9animation"},{"key":"2460_CR34","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1007\/s00134-012-2675-0","volume":"38","author":"K Razazi","year":"2012","unstructured":"Razazi K, Derde LPG, Verachten M, Legrand P, Lesprit P, Brun-Buisson C. Clinical impact and risk factors for colonization with extended-spectrum \u03b2-lactamase-producing bacteria in the intensive care unit. Intensive Care Med. 2012;38:1769\u201378.","journal-title":"Intensive Care Med"},{"key":"2460_CR35","first-page":"e12445","volume-title":"Extended-spectrum \u03b2-lactamase-producing E. coli septicemia among rectal carriers in the ICU: Medicine (Baltimore)","author":"M Liu","year":"2018","unstructured":"Liu M, Li M, Wu L, Song Q, Zhao D, Chen Z, et al. Extended-spectrum \u03b2-lactamase-producing E. coli septicemia among rectal carriers in the ICU: Medicine (Baltimore), vol. 97; 2018. p. e12445."},{"key":"2460_CR36","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1089\/mdr.2006.12.50","volume":"12","author":"IS Martins","year":"2006","unstructured":"Martins IS, Pessoa-Silva CL, Nouer SA, Pessoa de Araujo EG, Ferreira ALP, Riley LW, et al. Endemic extended-spectrum beta-lactamase-producing Klebsiella pneumoniae at an intensive care unit: risk factors for colonization and infection. Microb Drug Resist. 2006;12:50\u20138.","journal-title":"Microb Drug Resist"},{"key":"2460_CR37","doi-asserted-by":"crossref","unstructured":"Razazi K, Mekontso Dessap A, Carteaux G, Jansen C, Decousser J-W, de Prost N, et al. Frequency, associated factors and outcome of multi-drug-resistant intensive care unit-acquired pneumonia among patients colonized with extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae. Ann Intensive Care. 2017;7 Available from: \n                    http:\/\/annalsofintensivecare.springeropen.com\/articles\/10.1186\/s13613-017-0283-4\n                    \n                  . [cited 2018 Oct 31].","DOI":"10.1186\/s13613-017-0283-4"},{"key":"2460_CR38","doi-asserted-by":"crossref","unstructured":"Carbonne H, Le Dorze M, Bourrel A-S, Poupet H, Poyart C, Cambau E, et al. Relation between presence of extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae in systematic rectal swabs and respiratory tract specimens in ICU patients. Ann Intensive Care. 2017;7 Available from: \n                    http:\/\/annalsofintensivecare.springeropen.com\/articles\/10.1186\/s13613-017-0237-x\n                    \n                  . [cited 2018 Oct 31].","DOI":"10.1186\/s13613-017-0237-x"},{"key":"2460_CR39","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1007\/s00134-018-5154-4","volume":"44","author":"F Barbier","year":"2018","unstructured":"for the OUTCOMEREA Study Group, Barbier F, Bailly S, Schwebel C, Papazian L, Azoulay \u00c9, et al. Infection-related ventilator-associated complications in ICU patients colonised with extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae. Intensive Care Med. 2018;44:616\u201326.","journal-title":"Intensive Care Med"},{"key":"2460_CR40","doi-asserted-by":"publisher","first-page":"e0201688","DOI":"10.1371\/journal.pone.0201688","volume":"13","author":"M Houard","year":"2018","unstructured":"Houard M, Rouz\u00e9 A, Ledoux G, Six S, Jaillette E, Poissy J, et al. Relationship between digestive tract colonization and subsequent ventilator-associated pneumonia related to ESBL-producing Enterobacteriaceae. Kou YR, editor. PLoS One. 2018;13:e0201688.","journal-title":"PLoS One"},{"key":"2460_CR41","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1093\/jac\/dkv423","volume":"71","author":"F Barbier","year":"2016","unstructured":"Barbier F, Pommier C, Essaied W, Garrouste-Orgeas M, Schwebel C, Ruckly S, et al. Colonization and infection with extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae in ICU patients: what impact on outcomes and carbapenem exposure? J Antimicrob Chemother. 2016;71:1088\u201397.","journal-title":"J Antimicrob Chemother"},{"key":"2460_CR42","doi-asserted-by":"publisher","first-page":"873","DOI":"10.7326\/0003-4819-110-11-873","volume":"110","author":"C Brun-Buisson","year":"1989","unstructured":"Brun-Buisson C, Legrand P, Rauss A, Richard C, Montravers F, Besbes M, et al. Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli. Study of an outbreak in an intensive care unit. Ann Intern Med. 1989;110:873\u201381.","journal-title":"Ann Intern Med"},{"key":"2460_CR43","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1086\/502521","volume":"26","author":"G Troch\u00e9","year":"2005","unstructured":"Troch\u00e9 G, Joly L-M, Guibert M, Zazzo J-F. Detection and treatment of antibiotic-resistant bacterial carriage in a surgical intensive care unit: a 6-year prospective survey. Infect Control Hosp Epidemiol. 2005;26:161\u20135.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2460_CR44","first-page":"200","volume":"73","author":"C Camus","year":"2016","unstructured":"Camus C, Sauvadet E, Tavenard A, Piau C, Uhel F, Bouju P, et al. Decline of multidrug-resistant Gram negative infections with the routine use of a multiple decontamination regimen in ICU. J Inf Secur. 2016;73:200\u20139.","journal-title":"J Inf Secur"},{"key":"2460_CR45","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1086\/514938","volume":"27","author":"D Decr\u00e9","year":"1998","unstructured":"Decr\u00e9 D, Gachot B, Lucet JC, Arlet G, Bergogne-B\u00e9r\u00e9zin E, R\u00e9gnier B. Clinical and bacteriologic epidemiology of extended-spectrum beta-lactamase-producing strains of Klebsiella pneumoniae in a medical intensive care unit. Clin Infect Dis. 1998;27:834\u201344.","journal-title":"Clin Infect Dis"},{"key":"2460_CR46","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1001\/jama.2018.13765","volume":"320","author":"BH Wittekamp","year":"2018","unstructured":"Wittekamp BH, Plantinga NL, Cooper BS, Lopez-Contreras J, Coll P, Mancebo J, et al. Decontamination strategies and bloodstream infections with antibiotic-resistant microorganisms in ventilated patients: a randomized clinical trial. JAMA. 2018;320:2087.","journal-title":"JAMA"},{"key":"2460_CR47","volume-title":"EUCIC medical guidelines on decolonization of multidrug-resistant gram-negative organisms","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli E. EUCIC medical guidelines on decolonization of multidrug-resistant gram-negative organisms; 2018."},{"key":"2460_CR48","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1186\/s12879-017-2590-7","volume":"17","author":"K Tissera","year":"2017","unstructured":"Tissera K, Liyanapathirana V, Dissanayake N, Pinto V, Ekanayake A, Tennakoon M, et al. Spread of resistant gram negatives in a Sri Lankan intensive care unit. BMC Infect Dis. 2017;17:490.","journal-title":"BMC Infect Dis"},{"key":"2460_CR49","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.jhin.2006.12.014","volume":"65","author":"LO Conterno","year":"2007","unstructured":"Conterno LO, Shymanski J, Ramotar K, Toye B, Zvonar R, Roth V. Impact and cost of infection control measures to reduce nosocomial transmission of extended-spectrum \u03b2-lactamase-producing organisms in a non-outbreak setting. J Hosp Infect. 2007;65:354\u201360.","journal-title":"J Hosp Infect"},{"key":"2460_CR50","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1093\/cid\/cis770","volume":"55","author":"S Tschudin-Sutter","year":"2012","unstructured":"Tschudin-Sutter S, Frei R, Dangel M, Stranden A, Widmer AF. Rate of transmission of extended-spectrum beta-lactamase-producing Enterobacteriaceae without contact isolation. Clin Infect Dis. 2012;55:1505\u201311.","journal-title":"Clin Infect Dis"},{"key":"2460_CR51","doi-asserted-by":"crossref","unstructured":"Souverein D, Euser SM, Herpers BL, Hattink C, Houtman P, Popma A, et al. No nosocomial transmission under standard hygiene precautions in short term contact patients in case of an unexpected ESBL or Q&A E. coli positive patient: a one-year prospective cohort study within three regional hospitals. Antimicrob Resist Infect Control. 2017;6 Available from: \n                    http:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-017-0228-6\n                    \n                  . [cited 2018 Oct 31].","DOI":"10.1186\/s13756-017-0228-6"},{"key":"2460_CR52","doi-asserted-by":"crossref","unstructured":"Zahar J-R, Poirel L, Dupont C, Fortineau N, Nassif X, Nordmann P. About the usefulness of contact precautions for carriers of extended-spectrum beta-lactamase-producing Escherichia coli. BMC Infect Dis. 2015;15 Available from: \n                    http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-015-1244-x\n                    \n                  . [cited 2018 Oct 31].","DOI":"10.1186\/s12879-015-1244-x"},{"key":"2460_CR53","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1007\/s00134-013-3071-0","volume":"39","author":"JR Zahar","year":"2013","unstructured":"Zahar JR, Garrouste-Orgeas M, Vesin A, Schwebel C, Bonadona A, Philippart F, et al. Impact of contact isolation for multidrug-resistant organisms on the occurrence of medical errors and adverse events. Intensive Care Med. 2013;39:2153\u201360.","journal-title":"Intensive Care Med"},{"key":"2460_CR54","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ajic.2008.04.257","volume":"37","author":"DJ Morgan","year":"2009","unstructured":"Morgan DJ, Diekema DJ, Sepkowitz K, Perencevich EN. Adverse outcomes associated with contact precautions: a review of the literature. Am J Infect Control. 2009;37:85\u201393.","journal-title":"Am J Infect Control"},{"key":"2460_CR55","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/cid\/cix825","volume":"66","author":"T Gurieva","year":"2018","unstructured":"Gurieva T, Dautzenberg MJD, Gniadkowski M, Derde LPG, Bonten MJM, Bootsma MCJ. The transmissibility of antibiotic-resistant Enterobacteriaceae in intensive care units. Clin Infect Dis. 2018;66:489\u201393.","journal-title":"Clin Infect Dis"},{"key":"2460_CR56","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1017\/ice.2018.63","volume":"39","author":"O Scheuerman","year":"2018","unstructured":"Scheuerman O, Schechner V, Carmeli Y, Guti\u00e9rrez-Guti\u00e9rrez B, Calbo E, Almirante B, et al. Comparison of predictors and mortality between bloodstream infections caused by ESBL-producing Escherichia coli and ESBL-producing Klebsiella pneumoniae. Infect Control Hosp Epidemiol. 2018;39:660\u20137.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2460_CR57","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/2047-2994-3-27","volume":"3","author":"JT Freeman","year":"2014","unstructured":"Freeman JT, Rubin J, McAuliffe GN, Peirano G, Roberts SA, Drinkovi\u0107 D, et al. Differences in risk-factor profiles between patients with ESBL-producing Escherichia coli and Klebsiella pneumoniae: a multicentre case-case comparison study. Antimicrob Resist Infect Control. 2014;3:27.","journal-title":"Antimicrob Resist Infect Control"},{"key":"2460_CR58","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1086\/673453","volume":"34","author":"JH Han","year":"2013","unstructured":"Han JH, Bilker WB, Nachamkin I, Zaoutis TE, Coffin SE, Linkin DR, et al. The effect of a hospital-wide urine culture screening intervention on the incidence of extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella species. Infect Control Hosp Epidemiol. 2013;34:1160\u20136.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2460_CR59","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.ajic.2017.02.001","volume":"45","author":"M Djibr\u00e9","year":"2017","unstructured":"Djibr\u00e9 M, Fedun S, Le Guen P, Vimont S, Hafiani M, Fulgencio J-P, et al. Universal versus targeted additional contact precautions for multidrug-resistant organism carriage for patients admitted to an intensive care unit. Am J Infect Control. 2017;45:728\u201334.","journal-title":"Am J Infect Control"},{"key":"2460_CR60","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13054-015-0754-7","volume":"19","author":"C Dananch\u00e9","year":"2015","unstructured":"Dananch\u00e9 C, B\u00e9net T, Allaouchiche B, Hernu R, Argaud L, Dauwalder O, et al. Targeted screening for third-generation cephalosporin-resistant Enterobacteriaceae carriage among patients admitted to intensive care units: a quasi-experimental study. Crit Care. 2015;19:38.","journal-title":"Crit Care"},{"key":"2460_CR61","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/cid\/cix258","volume":"65","author":"S Tschudin-Sutter","year":"2017","unstructured":"Tschudin-Sutter S, Lucet J-C, Mutters NT, Tacconelli E, Zahar JR, Harbarth S. Contact precautions for preventing nosocomial transmission of extended-spectrum \u03b2 lactamase\u2013producing Escherichia coli: a point\/counterpoint review. Clin Infect Dis. 2017;65:342\u20137.","journal-title":"Clin Infect Dis"},{"key":"2460_CR62","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s15010-014-0619-z","volume":"42","author":"D Vodovar","year":"2014","unstructured":"Vodovar D, Marcad\u00e9 G, Rousseau H, Raskine L, Vicaut E, Deye N, et al. Predictive factors for extended-spectrum beta-lactamase producing Enterobacteriaceae causing infection among intensive care unit patients with prior colonization. Infection. 2014;42:743\u20138.","journal-title":"Infection"},{"key":"2460_CR63","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.jhin.2013.04.018","volume":"84","author":"T Goulenok","year":"2013","unstructured":"Goulenok T, Ferroni A, Bille E, L\u00e9cuyer H, Join-Lambert O, Descamps P, et al. Risk factors for developing ESBL E. coli: can clinicians predict infection in patients with prior colonization? J Hosp Infect. 2013;84:294\u20139.","journal-title":"J Hosp Infect"},{"key":"2460_CR64","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/cid\/cix270","volume":"65","author":"CL Gorrie","year":"2017","unstructured":"Gorrie CL, Mir\u010deta M, Wick RR, Edwards DJ, Thomson NR, Strugnell RA, et al. Gastrointestinal carriage is a major reservoir of Klebsiella pneumoniae infection in intensive care patients. Clin Infect Dis. 2017;65:208\u201315.","journal-title":"Clin Infect Dis"},{"key":"2460_CR65","doi-asserted-by":"publisher","first-page":"e0158039","DOI":"10.1371\/journal.pone.0158039","volume":"11","author":"C Sakellariou","year":"2016","unstructured":"Sakellariou C, G\u00fcrntke S, Steinmetz I, Kohler C, Pfeifer Y, Gastmeier P, et al. Sepsis caused by extended-spectrum beta-lactamase (ESBL)-Positive K. pneumoniae and E. coli: comparison of severity of sepsis, delay of anti-infective therapy and ESBL genotype. Yam WC, editor. PLoS One. 2016;11:e0158039.","journal-title":"PLoS One"},{"key":"2460_CR66","first-page":"293","volume":"26","author":"M Falcone","year":"2014","unstructured":"Falcone M, Vena A, Mezzatesta ML, Gona F, Caio C, Goldoni P, et al. Role of empirical and targeted therapy in hospitalized patients with bloodstream infections caused by ESBL-producing Enterobacteriaceae. Ann Ig Med Prev E Comunita. 2014;26:293\u2013304.","journal-title":"Ann Ig Med Prev E Comunita"},{"key":"2460_CR67","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1007\/s10096-017-3031-7","volume":"36","author":"E-J Joo","year":"2017","unstructured":"Joo E-J, Park DA, Lee NR, Moon S-Y, Choi J-K, Ko J-H, et al. Impact of appropriateness of empiric therapy on outcomes in community-onset bacteremia by extended-spectrum-\u03b2-lactamase producing Escherichia coli and Klebisella pneumoniae definitively treated with carbapenems. Eur J Clin Microbiol Infect Dis. 2017;36:2093\u2013100.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2460_CR68","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ijantimicag.2009.11.015","volume":"35","author":"D Vogelaers","year":"2010","unstructured":"Vogelaers D, De Bels D, For\u00eat F, Cran S, Gilbert E, Schoonheydt K, et al. Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates--a multicentre, observational survey in critically ill patients. Int J Antimicrob Agents. 2010;35:375\u201381.","journal-title":"Int J Antimicrob Agents"},{"key":"2460_CR69","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1001\/jama.2018.12163","volume":"320","author":"PNA Harris","year":"2018","unstructured":"Harris PNA, Tambyah PA, Lye DC, Mo Y, Lee TH, Yilmaz M, et al. Effect of piperacillin-Tazobactam vs Meropenem on 30-day mortality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a randomized clinical trial. JAMA. 2018;320:984.","journal-title":"JAMA"},{"key":"2460_CR70","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1001\/jama.2018.19349","volume":"321","author":"R Prevel","year":"2019","unstructured":"Prevel R, Berda\u00ef D, Boyer A. Antibiotics for ceftriaxone-resistant Gram-negative bacterial bloodstream infections. JAMA. 2019;321:613.","journal-title":"JAMA"},{"key":"2460_CR71","first-page":"293","volume":"73","author":"A Boucher","year":"2016","unstructured":"Boucher A, Meybeck A, Patoz P, Valette M, Thellier D, Delannoy PY, et al. Alternatives to carbapenems in ventilator-associated pneumonia due to ESBL-producing Enterobacteriaceae. J Inf Secur. 2016;73:293\u20136.","journal-title":"J Inf Secur"},{"key":"2460_CR72","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S1473-3099(17)30747-8","volume":"18","author":"A Torres","year":"2018","unstructured":"Torres A, Zhong N, Pachl J, Timsit J-F, Kollef M, Chen Z, et al. Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial. Lancet Infect Dis. 2018;18:285\u201395.","journal-title":"Lancet Infect Dis"},{"key":"2460_CR73","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/S0140-6736(14)62220-0","volume":"385","author":"FM Wagenlehner","year":"2015","unstructured":"Wagenlehner FM, Umeh O, Steenbergen J, Yuan G, Darouiche RO. Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI). Lancet. 2015;385:1949\u201356.","journal-title":"Lancet"},{"key":"2460_CR74","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1055\/s-0037-1603112","volume":"38","author":"J-F Timsit","year":"2017","unstructured":"Timsit J-F, Pilmis B, Zahar J-R. How should we treat hospital-acquired and ventilator-associated pneumonia caused by extended-spectrum \u03b2-lactamase\u2013producing Enterobacteriaceae? Semin Respir Crit Care Med. 2017;38:287\u2013300.","journal-title":"Semin Respir Crit Care Med"},{"key":"2460_CR75","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13756-018-0356-7","volume":"7","author":"MJD Dautzenberg","year":"2018","unstructured":"Dautzenberg MJD, Bayjanov JR, Leverstein-van Hall MA, Muller AE, Gelinck LBS, Jansen CL, et al. Dynamics of colistin and tobramycin resistance among Enterobacter cloacae during prolonged use of selective decontamination of the digestive tract. Antimicrob Resist Infect Control. 2018;7:67.","journal-title":"Antimicrob Resist Infect Control"},{"key":"2460_CR76","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1128\/AAC.02634-12","volume":"57","author":"T Halaby","year":"2013","unstructured":"Halaby T, Al Naiemi N, Kluytmans J, van der Palen J, Vandenbroucke-Grauls CMJE. Emergence of colistin resistance in Enterobacteriaceae after the introduction of selective digestive tract decontamination in an intensive care unit. Antimicrob Agents Chemother. 2013;57:3224\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"2460_CR77","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1093\/jac\/dkl316","volume":"58","author":"N Al Naiemi","year":"2006","unstructured":"Al Naiemi N, Heddema ER, Bart A, de Jonge E, Vandenbroucke-Grauls CM, Savelkoul PHM, et al. Emergence of multidrug-resistant Gram-negative bacteria during selective decontamination of the digestive tract on an intensive care unit. J Antimicrob Chemother. 2006;58:853\u20136.","journal-title":"J Antimicrob Chemother"},{"key":"2460_CR78","doi-asserted-by":"crossref","unstructured":"Huttner B, Haustein T, Uckay I, Renzi G, Stewardson A, Schaerrer D, et al. Decolonization of intestinal carriage of extended-spectrum -lactamase-producing Enterobacteriaceae with oral colistin and neomycin: a randomized, double-blind, placebo-controlled trial. J Antimicrob Chemother. 2013; Available from: \n                    https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkt174\n                    \n                  . [cited 2018 Oct 31].","DOI":"10.1093\/jac\/dkt174"},{"key":"2460_CR79","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1128\/AAC.01528-15","volume":"60","author":"MJ Gosalbes","year":"2016","unstructured":"Gosalbes MJ, V\u00e1zquez-Castellanos JF, Angebault C, Woerther P-L, Rupp\u00e9 E, Ferr\u00fas ML, et al. Carriage of Enterobacteria producing extended-spectrum \u03b2-lactamases and composition of the gut microbiota in an Amerindian community. Antimicrob Agents Chemother. 2016;60:507\u201314.","journal-title":"Antimicrob Agents Chemother"},{"key":"2460_CR80","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1093\/cid\/ciw426","volume":"63","author":"R Araos","year":"2016","unstructured":"Araos R, Tai AK, Snyder GM, Blaser MJ, D\u2019Agata EMC. Predominance of Lactobacillus spp. among patients who do not acquire multidrug-resistant organisms. Clin Infect Dis. 2016;63:937\u201343.","journal-title":"Clin Infect Dis"},{"key":"2460_CR81","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1093\/cid\/cix252","volume":"65","author":"J Bilinski","year":"2017","unstructured":"Bilinski J, Grzesiowski P, Sorensen N, Madry K, Muszynski J, Robak K, et al. Fecal microbiota transplantation in patients with blood disorders inhibits gut colonization with antibiotic-resistant bacteria: results of a prospective, single-center study. Clin Infect Dis. 2017;65:364\u201370.","journal-title":"Clin Infect Dis"},{"key":"2460_CR82","doi-asserted-by":"publisher","first-page":"O977","DOI":"10.1111\/1469-0691.12683","volume":"20","author":"R Singh","year":"2014","unstructured":"Singh R, van Nood E, Nieuwdorp M, van Dam B, ten Berge IJM, Geerlings SE, et al. Donor feces infusion for eradication of extended Spectrum beta-lactamase producing Escherichia coli in a patient with end stage renal disease. Clin Microbiol Infect. 2014;20:O977\u20138.","journal-title":"Clin Microbiol Infect"},{"key":"2460_CR83","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13104-018-3293-x","volume":"11","author":"R Singh","year":"2018","unstructured":"Singh R, de Groot PF, Geerlings SE, Hodiamont CJ, Belzer C, Berge IJMT, et al. Fecal microbiota transplantation against intestinal colonization by extended spectrum beta-lactamase producing Enterobacteriaceae: a proof of principle study. BMC Res Notes. 2018;11:190.","journal-title":"BMC Res Notes"},{"key":"2460_CR84","doi-asserted-by":"publisher","unstructured":"Huttner BD, de Lastours V, Wassenberg M, Maharshak N, Mauris A, Galperine T, et al. A five-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant Enterobacteriaceae: a randomized clinical trial. Clin Microbiol Infect. 2019. \n                    https:\/\/doi.org\/10.1016\/j.cmi.2018.12.009\n                    \n                  .","DOI":"10.1016\/j.cmi.2018.12.009"},{"key":"2460_CR85","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.cmi.2018.05.020","volume":"24","author":"E Rupp\u00e9","year":"2018","unstructured":"Rupp\u00e9 E, Martin-Loeches I, Rouz\u00e9 A, Levast B, Ferry T, Timsit J-F. What\u2019s new in restoring the gut microbiota in ICU patients? Potential role of faecal microbiota transplantation. Clin Microbiol Infect. 2018;24:803\u20135.","journal-title":"Clin Microbiol Infect"},{"key":"2460_CR86","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.chom.2017.04.002","volume":"21","author":"S Caballero","year":"2017","unstructured":"Caballero S, Kim S, Carter RA, Leiner IM, Su\u0161ac B, Miller L, et al. Cooperating commensals restore colonization resistance to vancomycin-resistant enterococcus faecium. Cell Host Microbe. 2017;21:592\u2013602 e4.","journal-title":"Cell Host Microbe"},{"key":"2460_CR87","doi-asserted-by":"crossref","unstructured":"Piewngam P, Qui\u00f1ones M, Thirakittiwatthana W, Yungyuen T, Otto M, Kiratisin P. Composition of the intestinal microbiota in extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae carriers and non-carriers in Thailand. Int J Antimicrob Agents. 2018; Available from: \n                    https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857918303686\n                    \n                  . [cited 2018 Dec 20].","DOI":"10.1016\/j.ijantimicag.2018.12.006"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-019-2460-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13054-019-2460-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-019-2460-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T23:29:50Z","timestamp":1589326190000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-019-2460-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,14]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2460"],"URL":"https:\/\/doi.org\/10.1186\/s13054-019-2460-3","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,14]]},"assertion":[{"value":"16 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AL, AMR, FMZ, RP, JRZ, and DG declare that they have no competing interests. AB reports congress fees from Pfizer and Gilead and a symposium moderation for Basilea.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"170"}}